摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-imino-2-(1H-1,2,4-triazol-5-ylsulfanyl)naphthalen-1-one

中文名称
——
中文别名
——
英文名称
4-imino-2-(1H-1,2,4-triazol-5-ylsulfanyl)naphthalen-1-one
英文别名
——
4-imino-2-(1H-1,2,4-triazol-5-ylsulfanyl)naphthalen-1-one化学式
CAS
——
化学式
C12H8N4OS
mdl
——
分子量
256.29
InChiKey
GEIYPPMECQOQNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    108
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Methods for inhibiting fascin
    申请人:Novita Pharmaceuticals, Inc.
    公开号:US10208043B2
    公开(公告)日:2019-02-19
    Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
    提供了用于治疗有需要的受试者中由 fascin 活性介导的病症或紊乱的组合物和方法,该方法包括向受试者施用治疗有效量的至少一种式 I-a 至 I-n、II、II-a、II-b 或 III 中任何一种的化合物或其药学上可接受的盐。
  • METHODS FOR INHIBITING FASCIN
    申请人:Cornell University
    公开号:US20140080843A1
    公开(公告)日:2014-03-20
    Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
  • [EN] METHODS FOR INHIBITING FASCIN<br/>[FR] MÉTHODES D'INHIBITION DE LA FASCINE
    申请人:UNIV CORNELL
    公开号:WO2014031732A2
    公开(公告)日:2014-02-27
    Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
查看更多